P-88 First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study
Titel:
P-88 First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study
Auteur:
Harrington, Kevin Siu, Lillian L. Burtness, Barbara Cohen, Ezra Licitra, Lisa Rischin, Danny Zhu, Ying Okpara, Chinyere E. Pinheiro, Cecilia Swaby, Ramona F. Machiels, Jean-Pascal Tahara, Makoto